Market Overview:
The global blood pressure disorders drug market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of hypertension and other blood pressure disorders, rising geriatric population, and growing awareness about blood pressure disorders. The global blood pressure disorders drug market is segmented on the basis of type into diuretics, angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and others. The diuretics segment is expected to account for the largest share of the global market in 2018 owing to their high usage in treating hypertension and other blood pressure disorders. The ACE inhibitors segment is projected to grow at a higher CAGR than other segments during the forecast period due to their high efficacy in controlling high blood pressure levels. On the basis of application, the global market is divided into hypertension, hypotension, pulmonary hypertension, and others. Hypertension accounted for majority share of this market in 2017 owing to its high prevalence across all regions globally.
Product Definition:
The term "blood pressure disorders" refers to a range of conditions that can affect the blood pressure. These conditions can include hypertension (high blood pressure), hypotension (low blood pressure), and other related disorders. Blood pressure is important because it helps to circulate blood throughout the body. Disorders that affect this vital measurement can lead to a variety of health problems.
Diuretics:
Diuretics are substances that increase urine production by the kidneys. The body normally makes a small amount of urine, but when more is needed, diuretics help the kidney to produce more. Diuretics are used for treating conditions such as congestive heart failure and edema (swelling caused due to high blood pressure).
Angiotensin Converting Enzyme (ACE) Inhibitors:
The global angiotensin converting enzyme (ACE) inhibitors market size was valued at USD 4.6 billion in 2015 and is expected to grow at a CAGR of XX% over the forecast period. The growing prevalence of hypertension, which accounts for nearly two-thirds of all adult deaths worldwide, is one of the key factors anticipated to drive growth during the forecast period.
Application Insights:
The hypertension segment dominated the global market in 2017 and is expected to continue its dominance over the forecast period. Hypertension increases the risk of cardiovascular diseases, which is one of the leading causes of death worldwide. According to a study published in The Lancet, around 31 million deaths occur due to CVDs globally every year. Furthermore, another study states that half of all strokes and about 40%of all heart attacks occur because of high blood pressure levels. Thus, it can be concluded that hypertension is a major public health problem which requires effective treatment options for reducing blood pressure levels as soon as possible.
ACE inhibitors were followed by angiotensin receptor blockers (ARBs) in terms both revenue and volume wise in 2017 due to their less prevalence compared to other BP drugs such as diuretics or beta-blockers but with better efficacy rates resulting in lesser adverse effects when compared with these two groups respectively.
Regional Analysis:
North America dominated the global blood pressure disorders drug market in 2017. The presence of key players, favorable reimbursement policies, and increasing awareness levels are some of the factors responsible for its large share. In addition, a high prevalence of hypertension among U.S population is driving growth in this region.
Growth Factors:
- Increasing prevalence of hypertension and other blood pressure disorders across the globe.
- Growing geriatric population susceptible to blood pressure disorders.
- Rising awareness about the early diagnosis and treatment of hypertension and other blood pressure disorders among people worldwide.
- Technological advancements in the field of diagnostics and therapeutics for hypertension and other blood pressure disorders .
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Pressure Disorders Drug Market Research Report
By Type
Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Others
By Application
Hypertension, Hypotension, Pulmonary Hypertension
By Companies
A1M Pharma AB, Acceleron Pharma Inc, Ache Laboratorios Farmaceuticos SA, Actelion Pharmaceuticals Ltd, Aerogen Ltd, Anavex Life Sciences Corp, AnGes Inc, Arena Pharmaceuticals Inc, Ascendia Pharmaceuticals LLC, Ascendis Pharma A/S, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Bioblue Technologies Inc, Biogen Inc, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Co, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc, Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp, Chugai Pharmaceutical Co Ltd, CJ HealthCare Corp, Complexa Inc, Corion Biotech Srl
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Blood Pressure Disorders Drug Market Report Segments:
The global Blood Pressure Disorders Drug market is segmented on the basis of:
Types
Diuretics, Angiotensin Converting Enzyme (ACE) Inhibitors, Angiotensin Receptor Blockers (ARBs), Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hypertension, Hypotension, Pulmonary Hypertension
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- A1M Pharma AB
- Acceleron Pharma Inc
- Ache Laboratorios Farmaceuticos SA
- Actelion Pharmaceuticals Ltd
- Aerogen Ltd
- Anavex Life Sciences Corp
- AnGes Inc
- Arena Pharmaceuticals Inc
- Ascendia Pharmaceuticals LLC
- Ascendis Pharma A/S
- AVEO Pharmaceuticals Inc
- Bayer AG
- Bial - Portela & Ca SA
- Bioblue Technologies Inc
- Biogen Inc
- Biolab Farmaceutica Ltda
- BioRestorative Therapies Inc
- Boryung Pharmaceutical Co Ltd
- Bristol-Myers Squibb Co
- Camurus AB
- Capricor Therapeutics Inc
- Celsion Corp
- Celtaxsys Inc
- Chiesi Farmaceutici SpA
- Chong Kun Dang Pharmaceutical Corp
- Chugai Pharmaceutical Co Ltd
- CJ HealthCare Corp
- Complexa Inc
- Corion Biotech Srl
Highlights of The Blood Pressure Disorders Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Diuretics
- Angiotensin Converting Enzyme (ACE) Inhibitors
- Angiotensin Receptor Blockers (ARBs)
- Others
- By Application:
- Hypertension
- Hypotension
- Pulmonary Hypertension
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Pressure Disorders Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A drug is a substance that, when ingested or inhaled, enters the body and affects normal biological functions. Drugs are classified by their chemical structure and how they work in the body.
Some of the major companies in the blood pressure disorders drug market are A1M Pharma AB, Acceleron Pharma Inc, Ache Laboratorios Farmaceuticos SA, Actelion Pharmaceuticals Ltd, Aerogen Ltd, Anavex Life Sciences Corp, AnGes Inc, Arena Pharmaceuticals Inc, Ascendia Pharmaceuticals LLC, Ascendis Pharma A/S, AVEO Pharmaceuticals Inc, Bayer AG, Bial - Portela & Ca SA, Bioblue Technologies Inc, Biogen Inc, Biolab Farmaceutica Ltda, BioRestorative Therapies Inc, Boryung Pharmaceutical Co Ltd, Bristol-Myers Squibb Co, Camurus AB, Capricor Therapeutics Inc, Celsion Corp, Celtaxsys Inc, Chiesi Farmaceutici SpA, Chong Kun Dang Pharmaceutical Corp, Chugai Pharmaceutical Co Ltd, CJ HealthCare Corp, Complexa Inc, Corion Biotech Srl.
The blood pressure disorders drug market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Blood Pressure Disorders Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Blood Pressure Disorders Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Blood Pressure Disorders Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Blood Pressure Disorders Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Blood Pressure Disorders Drug Market Size & Forecast, 2018-2028
4.5.1 Blood Pressure Disorders Drug Market Size and Y-o-Y Growth
4.5.2 Blood Pressure Disorders Drug Market Absolute $ Opportunity
Chapter 5 Global Blood Pressure Disorders Drug Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Blood Pressure Disorders Drug Market Size Forecast by Type
5.2.1 Diuretics
5.2.2 Angiotensin Converting Enzyme (ACE) Inhibitors
5.2.3 Angiotensin Receptor Blockers (ARBs)
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Blood Pressure Disorders Drug Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Blood Pressure Disorders Drug Market Size Forecast by Applications
6.2.1 Hypertension
6.2.2 Hypotension
6.2.3 Pulmonary Hypertension
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Blood Pressure Disorders Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Blood Pressure Disorders Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Blood Pressure Disorders Drug Analysis and Forecast
9.1 Introduction
9.2 North America Blood Pressure Disorders Drug Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Blood Pressure Disorders Drug Market Size Forecast by Type
9.6.1 Diuretics
9.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
9.6.3 Angiotensin Receptor Blockers (ARBs)
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Blood Pressure Disorders Drug Market Size Forecast by Applications
9.10.1 Hypertension
9.10.2 Hypotension
9.10.3 Pulmonary Hypertension
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Blood Pressure Disorders Drug Analysis and Forecast
10.1 Introduction
10.2 Europe Blood Pressure Disorders Drug Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Blood Pressure Disorders Drug Market Size Forecast by Type
10.6.1 Diuretics
10.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
10.6.3 Angiotensin Receptor Blockers (ARBs)
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Blood Pressure Disorders Drug Market Size Forecast by Applications
10.10.1 Hypertension
10.10.2 Hypotension
10.10.3 Pulmonary Hypertension
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Blood Pressure Disorders Drug Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Blood Pressure Disorders Drug Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Blood Pressure Disorders Drug Market Size Forecast by Type
11.6.1 Diuretics
11.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
11.6.3 Angiotensin Receptor Blockers (ARBs)
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Blood Pressure Disorders Drug Market Size Forecast by Applications
11.10.1 Hypertension
11.10.2 Hypotension
11.10.3 Pulmonary Hypertension
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Blood Pressure Disorders Drug Analysis and Forecast
12.1 Introduction
12.2 Latin America Blood Pressure Disorders Drug Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Blood Pressure Disorders Drug Market Size Forecast by Type
12.6.1 Diuretics
12.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
12.6.3 Angiotensin Receptor Blockers (ARBs)
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Blood Pressure Disorders Drug Market Size Forecast by Applications
12.10.1 Hypertension
12.10.2 Hypotension
12.10.3 Pulmonary Hypertension
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Blood Pressure Disorders Drug Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Blood Pressure Disorders Drug Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Blood Pressure Disorders Drug Market Size Forecast by Type
13.6.1 Diuretics
13.6.2 Angiotensin Converting Enzyme (ACE) Inhibitors
13.6.3 Angiotensin Receptor Blockers (ARBs)
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Blood Pressure Disorders Drug Market Size Forecast by Applications
13.10.1 Hypertension
13.10.2 Hypotension
13.10.3 Pulmonary Hypertension
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Blood Pressure Disorders Drug Market: Competitive Dashboard
14.2 Global Blood Pressure Disorders Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 A1M Pharma AB
14.3.2 Acceleron Pharma Inc
14.3.3 Ache Laboratorios Farmaceuticos SA
14.3.4 Actelion Pharmaceuticals Ltd
14.3.5 Aerogen Ltd
14.3.6 Anavex Life Sciences Corp
14.3.7 AnGes Inc
14.3.8 Arena Pharmaceuticals Inc
14.3.9 Ascendia Pharmaceuticals LLC
14.3.10 Ascendis Pharma A/S
14.3.11 AVEO Pharmaceuticals Inc
14.3.12 Bayer AG
14.3.13 Bial - Portela & Ca SA
14.3.14 Bioblue Technologies Inc
14.3.15 Biogen Inc
14.3.16 Biolab Farmaceutica Ltda
14.3.17 BioRestorative Therapies Inc
14.3.18 Boryung Pharmaceutical Co Ltd
14.3.19 Bristol-Myers Squibb Co
14.3.20 Camurus AB
14.3.21 Capricor Therapeutics Inc
14.3.22 Celsion Corp
14.3.23 Celtaxsys Inc
14.3.24 Chiesi Farmaceutici SpA
14.3.25 Chong Kun Dang Pharmaceutical Corp
14.3.26 Chugai Pharmaceutical Co Ltd
14.3.27 CJ HealthCare Corp
14.3.28 Complexa Inc
14.3.29 Corion Biotech Srl
